Explore Global Companies & Account Intelligence

NeuronicLABs is a Toronto-based medical device company focused on designing, developing, and manufacturing next-generation molecular diagnostics. Employing cutting-edge technologies at the intersection of nanotechnology, artificial intelligence, and robotics, NeuronicLABs’ mission is to democratize molecular diagnostics at the point of care by providing high-quality molecular testing accessible to everyone and providing a safe environment for healthcare professionals.

A Neurônio Adicional ou NA+ é a estrutura criada pela Ziil Propaganda para atender os serviços de web como Produção de Sites, Redes Sociais e SEO. A NA+ vem ganhando cada vez mais destaque no mercado por trazer as tendências de Web apontadas nos principais eventos da área dos últimos anos, com sites integrado às redes sociais, com versões especiais para celulares, com planejamento de ações e monitoramento para avaliação exata dos resultados.

Neuronoff, Inc. is developing new medical devices utilizing neuromodulation to restore & improve organ activity in the human body. The primary focus is on treatments for chronic pain.

Map your farm with drones and AI to find issues before they escalate into costly problems CBD Hemp farms avoid extreme losses caused by pollination AI-driven software analyzes drone images to map locations of male plants for faster removal Accurate plant count, field analytics, and early diagnosis Critical information highlighted in large maps. Multispectral imaging to spot unhealthy plants early

We offer support and education to help those in Texas more effectively live with neuropathy. Our hope is that this information, together with the sharing and sense of community that occurs at our monthly support group meetings, will give you the tools you need to minimize the effect that peripheral neuropathy has on your life.

Comprehensive enterprise dossier available in global intelligence registry.

We are proud to be the first comprehensive Pediatric Neurosciences Center in UAE, which provides world-class expertise in neurological, psychological, behavioural and rehabilitative science.

Comprehensive enterprise dossier available in global intelligence registry.

Comprehensive enterprise dossier available in global intelligence registry.

NEUROPUBLIC (www.neuropublic.gr) is an innovative ICT SME specialized in the development of integrated information systems and high-demand applications built in Cloud Computing architecture. The company has built and operates its own data center, offering cloud services at platform level (PaaS) and software level (SaaS). Its products and services are being successfully used for over 10 years, by more than 800.000 end-users in agriculture, local government and healthcare. NEUROPUBLIC is the company that develops all the technological components of the innovative gaiasense smart farming system (www.gaiasense.gr), namely the software, telemetric stations (ultra-low cost, very flexible/mobile and scalable agri-sensors for the monitoring of environmental and soil variables) and computing systems. In addition, it has the operational responsibility for the development and operation of the station system throughout Greece. NEUROPUBLIC has a strong participation in EC-funded projects, such as the Horizon 2020 DataBio, IoF2020, SmartAgriHubs, NIVA, PoliRural, e-shape & OchraVine Control, the LIFE GAIA Sense project and FP7 LASIE & ADVISE projects. The company also has a long time collaboration with the European Space Agency (ESA), and has been working on related projects such as Euro-VO Registry, Space Certifiable Compiler Extensions, Data Modelling Technologies, EGOS Coding Convention and Quality Model etc. The company invests considerable amount of money in R&D (>3 million euros for the years 2013-2017) and implements the research results on innovative products that satisfy the demands of the future and the new trend markets.

NeuroQuest is developing biomarkers for the early and accurate diagnosis of Alzheimer’s and ALS Diseases. NeuroQuest's diagnostics are blood-based immune biomarkers in AD and ALS patients. Blood samples are processed by standard laboratory approaches to measure novel and patent pending aspects of the peripheral immune system that reflect the disease pathology and can be used for diagnosis, prognosis, and monitoring disease progression. These patented biomarkers may lead to a better understanding of the mechanism of neurodegenerative disease, leading to improved therapeutics. NeuroQuest is a portfolio company of the Trendlines Group, with additional investments from the Maryland-Israel Trendlines Fund, and the InterTech Group.

NeuroRex Inc. is a small medical company in Houston developing non-invasive novel sensors for neuro-diagnostic and electrophysiology biomarkers.